Q4: 2026-03-09 Earnings SummaryEPS of -$1.43 misses by $0.40
|
Revenue of
$284.00K
(-78.57% Y/Y)
misses by $164.25K
Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP March 9, 2026 8:00 AM EDT
Company Participants
Marino Garcia - President, CEO & Director
Simrat Randhawa - Executive VP and Head of R&D
Conference Call Participants
Yatin Suneja - Guggenheim Securities, LLC, Research Division
Alexander Thompson - Stifel, Nicolaus & Company, Incorporated, Research Division
Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division
Gavin Clark-Gartner - Evercore ISI Institutional Equities, Research Division
Yaron Werber - TD Cowen, Research Division
Rami Katkhuda - LifeSci Capital, LLC, Research Division
Maurice Raycroft - Jefferies LLC, Research Division
Danielle Brill Bongero - Truist Securities, Inc., Research Division
Ryan Deschner - Raymond James & Associates, Inc., Research Division
Colleen Hanley - Robert W. Baird & Co. Incorporated, Research Division
William Maughan - Clear Street LLC., Research Division
K. Pak - Wedbush Securities Inc., Research Division
Jake Batchelder - William Blair & Company L.L.C., Research Division
Presentation
Operator
Good morning, and welcome to the Dianthus Therapeutics Conference Call. My name is Michelle, and I'll be your operator for today's call. A slide presentation to accompany the call is available on the Investors section of the Dianthus Therapeutics website. Following the company's prepared remarks, we will move to a Q&A session. Please note that today's call is being recorded. I will now turn the call over to Marino Garcia, CEO of Dianthus Therapeutics. You may begin.
Marino Garcia
President, CEO & Director
Thank you, operator. Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release with our early go decision for the interim responder analysis for our CAPTIVATE trial in CIDP, and we are thrilled to share with you more today on this call. This earlier-than-anticipated announcement reflects the Dianthus team's commitment and passion for patients suffering from severe neuromuscular diseases.
And
2026-03-10 01:231mo ago
2026-03-09 20:471mo ago
Hewlett Packard Enterprise Company (HPE) Q1 2026 Earnings Call Transcript
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced the closing of its previously announced underwritten public offering and the exercise in full of the underwriters’ over-allotment option for gross proceeds of approximately $6.0 million, prior to deducting underwriting commissions and offering expenses.
In connection with the offering, the Company sold 12,094,631 shares of common stock (or pre-funded warrants in lieu thereof) Series J warrants to purchase 12,094,631 shares of common stock, Series K warrants to purchase 12,094,631 shares of common stock, and Series L warrants to purchase 12,094,631 shares of common stock, including the full exercise of the underwriter’s option to purchase 1,575,000 shares of common stock and accompanying warrants..
Ladenburg Thalmann & Co. Inc. acted as sole book-running manager for the offering.
The securities described above were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-284229), which was declared effective by the United States Securities and Exchange Commission (“SEC”) on February 7, 2025 and the related registration statement filed under Rule 462(b) of the Securities Act of 1933, as amended, which became automatically effective upon filing. A final prospectus supplement was filed with the SEC and is available on the SEC’s website at http://www.sec.gov. Electronic copies of the final prospectus may also be obtained by contacting Ladenburg Thalmann & Co. Inc., Prospectus Department, 640 Fifth Avenue, 4th Floor, New York, New York 10019 or by email at [email protected].
The Series J warrant has an initial exercise price of $0.50 per share, is exercisable upon issuance, and has a term expiring five years from issuance. The Series K warrant has an initial exercise price of $0.50 per share, is exercisable upon issuance, and has a term expiring one year from issuance. The Series L warrant has an initial exercise price of $0.50 per share, is exercisable upon issuance, and has a term expiring six months from issuance. The warrants issued in this offering each include a reset of the exercise price on two separate occasions: (i) on the forty-fifth (45th) calendar day following the date of issuance and (ii) the sixth (6th) trading day immediately following the date on which a reverse stock split is approved and deemed effective during the fiscal year ended December 31, 2026.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
About Calidi Biotherapeutics
Calidi Biotherapeutics (NYSE American: CLDI) is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company’s proprietary Redtail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations.
CLD-401, the lead candidate from the Redtail platform, currently in IND-enabling studies, targets non-small cell lung cancer, head and neck cancer, and other tumor types with high unmet medical need. Calidi continues to advance its pipeline utilizing the Redtail platform including its novel approach to incorporate BiTEs in solid tumors.
Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit www.calidibio.com or view Calidi’s Corporate Presentation here.
Forward-Looking Statements
This press release may contain forward-looking statements for purposes of the “safe harbor” provisions under the United States Private Securities Litigation Reform Act of 1995. Terms such as “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predicts,” “project,” “should,” “towards,” “would” as well as similar terms, are forward-looking in nature, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements concerning key milestones, including certain pre-clinical data, planned clinical trials, and statements relating to the safety and efficacy of Calidi’s therapeutic candidates in development. Any forward-looking statements contained in this discussion are based on Calidi’s current expectations and beliefs concerning future developments and their potential effects and are subject to multiple risks and uncertainties that could cause actual results to differ materially and adversely from those set forth or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that Calidi is not able to raise sufficient capital to support its current and anticipated clinical trials, the risk that early results of clinical trials do not necessarily predict final results and that one or more of the clinical outcomes may materially change following more comprehensive review of the data, and as more patient data becomes available, the risk that Calidi may not receive FDA approval for some or all of its therapeutic candidates. Other risks and uncertainties are set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Company’s annual report filed with the SEC on Form 10-K on March 31, 2025, as may be amended or supplemented by other reports we file with the SEC from time to time. We disclaim any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
For Investors:
Dave Gentry, CEO
RedChip Companies, Inc.
1-407-644-4256 [email protected]
2026-03-10 01:231mo ago
2026-03-09 20:561mo ago
Arq, Inc. (ARQ) Reports Q4 Loss, Misses Revenue Estimates
Arq, Inc. (ARQ - Free Report) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -55.56%. A quarter ago, it was expected that this company would post earnings of $0.02 per share when it actually produced a loss of $0.02, delivering a surprise of -200%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Arq, Inc., which belongs to the Zacks Chemical - Specialty industry, posted revenues of $29.43 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.43%. This compares to year-ago revenues of $27.04 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Arq, Inc. shares have lost about 1.8% since the beginning of the year versus the S&P 500's decline of 1.5%.
What's Next for Arq, Inc.?While Arq, Inc. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Arq, Inc. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.06 on $29.5 million in revenues for the coming quarter and -$0.03 on $136.77 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the bottom 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, H. B. Fuller (FUL - Free Report) , is yet to report results for the quarter ended February 2026.
This adhesives company is expected to post quarterly earnings of $0.56 per share in its upcoming report, which represents a year-over-year change of +3.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
H. B. Fuller's revenues are expected to be $790.1 million, up 0.2% from the year-ago quarter.
2026-03-10 01:231mo ago
2026-03-09 20:571mo ago
Nexcel Files Final Short Form Base Shelf Prospectus
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Nexcel Metals Corp. (CSE: NEXX) (OTCQB: NXXCF) (FSE: 2OH) ("Nexcel" or the "Company") is pleased to announce that it has filed a final short form base shelf prospectus with the securities regulatory authorities in each of the provinces and territories of Canada.
Nexcel has filed this final base shelf prospectus in order to provide the Company with greater financial flexibility going forward but has not yet entered into any agreements to authorize or offer any securities.
The base shelf prospectus will allow the Company to offer and issue common shares, warrants, subscription receipts, debt securities, units or any combination thereof for up to an aggregate offering price of $25,000,000 during the 25-month period that the base shelf prospectus is effective across one or more transactions. The specific terms of any offering of securities under the base shelf prospectus, including the use of proceeds from any offering, will be set forth in a shelf prospectus supplement which will be filed with the applicable Canadian securities regulatory authorities.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state or jurisdiction.
A copy of the final short form base shelf prospectus can be found on SEDAR+ at www.sedarplus.ca.
About Nexcel Metals Corp.
Nexcel is a junior mining company engaged in the acquisition, exploration and development of mineral properties. The Company is currently focused on the Lac Ducharme Property located in the Province of Québec and the Burnt Hill Property located in the Province of New Brunswick.
ON BEHALF OF THE BOARD OF DIRECTORS
"Hugh Rogers"
CEO
Forward-Looking Statements
This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions (including negative and grammatical variations), or that events or conditions "will," "would," "may," "could" or "should" occur. All statements other than statements of historical fact in this news release are forward-looking statements that involve risks and uncertainties.
These forward-looking statements relate to, among other things, statements regarding the filing, potential receipt of a final receipt for, and effectiveness of the Company's final short form base shelf prospectus; the Company's potential future offerings of securities thereunder (including the timing, size—up to an aggregate offering price of $25,000,000 over the 25-month period that the base shelf prospectus is effective—structure and terms of any such offerings). There can be no assurance that such statements will prove to be accurate. The Company has no obligation to issue any securities as described herein or at all. Actual results and future events could differ materially. Forward-looking information is based on management's reasonable assumptions and expectations, including, among other things, the timely receipt of required approvals from any applicable stock exchange, market conditions and investor demand. Although the Company believes these assumptions and expectations are reasonable, there can be no assurance they will prove correct. Actual results may differ materially due to a variety of risks and uncertainties, including, without limitation: that the Company may decide not to proceed with any offering under the base shelf prospectus; adverse market conditions or insufficient investor demand; failure to obtain required regulatory or stock exchange approvals; and the other risk factors described in the Company's continuous disclosure filings available under the Company's profile on SEDAR+ at www.sedarplus.ca.
Forward-looking information is made as of the date of this news release, and the Company undertakes no obligation to update or revise any forward-looking information, except as required by applicable securities laws.
The Canadian Securities Exchange and the Market Regulator (as defined in the policies of the Canadian Securities Exchange) have not reviewed, approved, disapproved or accepted responsibility for the contents, adequacy or accuracy of this news release.
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/287876
Source: Nexcel Metals Corp.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-10 01:231mo ago
2026-03-09 20:571mo ago
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT
Company Participants
Carrie Graham - Vice President of Investor Relations & Advocacy
Dennis Lanfear - Chairman, President & CEO
Theresa Lavallee - Chief Development Officer & Chairman of Scientific Advisory Board
Rosh Dias - Chief Medical Officer
Sameer Goregaoker - Chief Commercial Officer
Bryan McMichael - Chief Financial Officer
Conference Call Participants
Jay Olson - Oppenheimer & Co. Inc., Research Division
Michael Nedelcovych - TD Cowen, Research Division
Colleen Hanley - Robert W. Baird & Co. Incorporated, Research Division
Lut Ming Cheng - JPMorgan Chase & Co, Research Division
Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Q4 and Full Year 2025 Coherus Oncology, Inc. Earnings Conference Call.
[Operator Instructions]
Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Carrie Graham. Please go ahead.
Carrie Graham
Vice President of Investor Relations & Advocacy
Thank you, Heidi. Good afternoon, and welcome to Coherus Oncology's Fourth Quarter and 2025 Year-end Earnings Conference Call. Joining me today to discuss our results are Denny Lanfear, Chief Executive Officer of Coherus; Dr. Theresa Lavallee, Chief Scientific and Development Officer; Dr. Rosh Dias, Chief Medical Officer; Sameer Goregaoker, Chief Commercial Officer; and Bryan McMichael, Chief Financial Officer.
Before we get started, I would like to remind you that today's call includes forward-looking statements regarding Coherus' current expectations about future events. Actual results may vary significantly, and we undertake no duty to update or revise any forward-looking statements. Please see the press release that we issued today and our annual report on Form 10-K for more information on risks and uncertainties.
And now I'll turn the call over to Denny.
Dennis
2026-03-10 01:231mo ago
2026-03-09 20:581mo ago
Vail Resorts, Inc. (MTN) Q2 2026 Earnings Call Transcript
Vail Resorts, Inc. (MTN) Q2 2026 Earnings Call March 9, 2026 5:00 PM EDT
Company Participants
Connie Wang
Robert Katz - CEO & Executive Chairman
Angela Korch - Executive VP & CFO
Conference Call Participants
Shaun Kelley - BofA Securities, Research Division
David Katz - Jefferies LLC, Research Division
Charles Scholes - Truist Securities, Inc., Research Division
Matthew Boss - JPMorgan Chase & Co, Research Division
Jeffrey Stantial - Stifel, Nicolaus & Company, Incorporated, Research Division
Arpine Kocharyan - UBS Investment Bank, Research Division
Benjamin Chaiken - Mizuho Securities USA LLC, Research Division
Xian Siew Hew Sam - BNP Paribas, Research Division
Brandt Montour - Barclays Bank PLC, Research Division
Chris Woronka - Deutsche Bank AG, Research Division
Stephen Grambling - Morgan Stanley, Research Division
Presentation
Operator
Good afternoon, and welcome to the Vail Resorts Fiscal Second Quarter 2026 Earnings Conference Call. Today's conference is being recorded. [Operator Instructions] I will now turn the call over to Connie Wang, Vice President of Investor Relations at Vail Resorts. You may begin.
Connie Wang
Thank you, operator. Good afternoon, everyone, and welcome to Vail Resorts Fiscal 2026 Second Quarter Earnings Conference Call. Joining me on the call today are Rob Katz, our Chief Executive Officer; and Angela Korch, our Chief Financial Officer. Before we begin, let me remind you that some information provided during this call may include forward-looking statements that are based on certain assumptions and are subject to a number of risks and uncertainties as described in our SEC filings, and actual future results may vary materially. Forward-looking statements in our press release issued this afternoon, along with our remarks on this call, are made as of today, March 9, 2026, and we undertake no duty to update them as actual events unfold.
Today's remarks also include certain non-GAAP financial measures. Reconciliations of these measures are provided in the tables
2026-03-10 01:231mo ago
2026-03-09 20:581mo ago
Securities Fraud Investigation Into Barclays PLC (BCS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BARCLAYS PLC (BCS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On February 27, 2026, the Financial Times reported that financial firms, “includin.
2026-03-10 01:231mo ago
2026-03-09 21:011mo ago
Oil falls over 6% as Trump predicts Middle East de-escalation
Item 1 of 2 Luojiashan tanker sits anchored in Muscat, as Iran vows to close the Strait of Hormuz, amid the U.S.-Israeli conflict with Iran, in Muscat, Oman, March 7, 2026. REUTERS/Benoit Tessier
[1/2]Luojiashan tanker sits anchored in Muscat, as Iran vows to close the Strait of Hormuz, amid the U.S.-Israeli conflict with Iran, in Muscat, Oman, March 7, 2026. REUTERS/Benoit Tessier Purchase Licensing Rights, opens new tab
SummaryOil prices fall after surging as high as $119 a barrel on MondayTrump predicted the war in the Middle East could be over soonG7 ready to act on oil surge but holds off tapping reservesCrude oil could trade in a wide range of around $75–$105 in the sessions ahead, analyst saysMarch 10 (Reuters) - Oil prices fell on Tuesday after hitting their highest level in more than three years in the prior session as U.S. President Donald Trump predicted the war in the Middle East could end soon, easing concerns about prolonged disruptions to global oil supplies.
Brent futures fell $6.51, or 6.6%, to $92.45 a barrel at 0018 GMT, while U.S. West Texas Intermediate (WTI) crude was down $6.12, or 6.5%, to $88.65.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
Oil prices surged past $100 a barrel on Monday, hitting session highs of $119.50 for Brent and $119.48 for WTI, their highest since mid-2022, as supply cuts by Saudi Arabia and other producers during the expanding U.S.-Israeli war with Iran stoked fears of major disruptions to global supplies.
Prices later retreated after Russian President Vladimir Putin held a call with Trump and shared proposals aimed at a quick settlement to the Iran war, according to a Kremlin aide, easing concerns about a prolonged supply disruption.
Trump said on Monday in a CBS News interview that he thinks the war against Iran "is very complete" and that Washington was "very far ahead" of his initial four- to five-week estimated timeframe.
In response to Trump, Iran's Revolutionary Guards (IRGC) said they would "determine the end of the war" and that Tehran would not allow "one litre of oil" to be exported from the region if U.S. and Israeli attacks continued, state media reported on Tuesday citing IRGC's spokesperson.
But those comments did not lift prices, which were also under pressure because Trump is considering easing oil sanctions on Russia and releasing emergency crude stockpiles as part of a package of options aimed at curbing spiking global oil prices amid the Iran conflict, according to multiple sources.
"Taking the events of the past 24 hours into account, I expect crude oil to remain highly volatile, trading within a wide range between $75ish and $105ish in the sessions ahead," Tony Sycamore, IG market analyst, said in a note.
Gulf oil producers have begun cutting output as the U.S.-Israeli war on Iran disrupted shipping in the region. Over the weekend, Iraq slashed production at its main southern oilfields by 70% to 1.3 million barrels per day while Kuwait Petroleum Corporation also began reducing output and declared force majeure.
Adding to the cuts, Saudi Arabia has now begun trimming production, sources said on Monday.
G7 nations said on Monday they were prepared to implement "necessary measures" in response to surging global oil prices but stopped short of committing to release emergency reserves.
Reporting by Anushree Mukherjee in Bengaluru; Editing by Jamie Freed
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-03-10 01:231mo ago
2026-03-09 21:081mo ago
ROSEN, TOP RANKED INVESTOR RIGHTS COUNSEL, Encourages Snowflake Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNOW
New York, New York--(Newsfile Corp. - March 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers Class A common stock of Snowflake Inc. (NYSE: SNOW) between June 27, 2023 and the close of the market on February 28, 2024 (4:00 p.m. ET), inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 27, 2026.
SO WHAT: If you purchased Snowflake Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Snowflake class action, go to https://rosenlegal.com/submit-form/?case_id=22950 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants repeatedly made positive statements about the state of its business, including positive statements about customer usage of, and new developments for, its products. At the same time, defendants failed to disclose that: (1) product efficiency gains, Iceberg Tables and tiered storage pricing were expected to have a material negative impact on consumption and revenues, and (2) as a result, defendants' positive statements about consumption patterns, revenues, and demand for Snowflake products lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Snowflake class action, go to https://rosenlegal.com/submit-form/?case_id=22950 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/287793
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-10 01:231mo ago
2026-03-09 21:161mo ago
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno common stock between March 26, 2025 and November 4, 2025.
The lawsuit follows Soleno’s November 5, 2025 report of disappointing information about DCCR (trademarked as VYKAT™ XR), a once-daily oral tablet intended to treat hyperphagia. Soleno has described this condition as “the most life-limiting aspect” of Prader-Willi Syndrome (“PWS”), a rare genetic disorder that causes physical, mental, and behavioral problems.
The report triggered a massive 26% selloff in the price of the company shares that day.
The development and severe market reaction have prompted national shareholders rights firm Hagens Berman to continue its investigation into whether Soleno violated the federal securities laws.
The firm urges investors in Soleno who suffered significant losses to submit your losses now.
Class Period: Mar. 26, 2025 – Nov. 4, 2025
Lead Plaintiff Deadline: May 5, 2026
Visit: www.hbsslaw.com/investor-fraud/slno
Contact the Firm Now: [email protected]
844-916-0895
Soleno Therapeutics, Inc. (SLNO) Securities Class Action:
The litigation focuses on the propriety of Soleno’s repeated statements concerning the safety, efficacy, and commercial prospects of DCCR. These included assurances that the launch of DCCR has been going “really well[]” and “definitely exceeded our expectations.”
More specifically, according to the lawsuit, the Soleno Phase 3 clinical program for DCCR had systematically downplayed, misrepresented, and/or concealed significant evidence of safety concerns potentially related to the administration of DCCR, including issues related to excess fluid retention in clinical trial participants. As a result, the administration of DCCR to treat hyperphagia in individuals with PWS posed significantly greater safety risks than disclosed by Soleno and its executives. The complaint further alleges that, due to the foregoing, DCCR had materially lower commercial viability and undisclosed risks about the likelihood of significant and widespread adverse events after its commercial launch.
Investors began to learn the truth back on August 15, 2025, when activist short seller Scorpion Capital raised questions about Soleno's disclosures and made several observations regarding VYKAT™ XR.
The firm noted a "rapid pile-up of reports of children hospitalized for potential heart failure" shortly after using the drug, leading Scorpion to conclude that VYKAT™ XR could be at risk of being withdrawn from the market or that new prescriptions might "plunge."
Furthermore, Scorpion alleged that Soleno's "launch metrics are hocus-pocus," claiming that the company was highly dependent on a "controversial physician" in Gainesville, Florida, who was the lead investigator on key trials. The report suggested this physician might be an "invisible hand fueling initial start forms."
Finally, Scorpion raised concerns about the physician's co-authored papers, alleging that they "exhibit irregularities consistent with red flags for data integrity and adherence to scientific standards, casting doubt onto the validity of SLNO’s trials, publications, and FDA submissions."
Most recently, during Soleno’s November 4, 2025 Q3 2025 earnings call, the company’s management revealed that “we did see a disruption in our launch trajectory in the wake of a short seller report that was released in August, mostly in the form of a lower number of start forms and increased discontinuations for non-serious adverse events.”
Since August 14, 2025 (the day before Scorpion published its report), by November 5, 2025 the price of Soleno shares has fallen nearly 40%.
“We’re investigating whether Soleno may have misled investors about the support it has said it has about the commercial prospects of VYKAT™ XR,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Soleno and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »
If you’d like more information and answers to frequently asked questions about the Soleno case and the firm’s investigation, read more »
Whistleblowers: Persons with non-public information regarding Soleno should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
2026-03-10 01:231mo ago
2026-03-09 21:201mo ago
From Panic to Power: 5 Reasons the Bulls Reclaimed the Market
Key Takeaways Crude oil futures reversed violently after a climactic rally.Market indices and tech leaders successfully defended long-term technical support. Excessive market fear suggests a vicious market rally is imminent. Monday, stocks stormed higher amid growing optimism about the Iranian Geopolitical conflict. Sunday night, the market picture looked less clear, with the major index futures each falling more than 1%. However, after a blood-red open, the bulls took control, as the major indices each finished the session up more than a percent on heavy turnover. For instance, the Nasdaq 100 Index ETF ((QQQ - Free Report) ) registered volume 54% above the norm, signaling heavy accumulation.
Below are five reasons stocks may have just bottomed:
1. Geopolitical Tensions are Cooling: Typically, geopolitical conflicts such as wars result in sharp, immediate, but short-lived price shocks in equity markets (with an average recovery period of 39 days). Monday, stocks suggested that would be the case after President Trump suggested that the war with Iran would be a “short-term” excursion.
2. Oil Reverses Violently: The calming rhetoric from President Trump finally helped bottle up oil prices. After ripping to $120 per barrel, U.S. crude oil futures reversed violently and closed below $90. Meanwhile, volume turnover on the United States Oil Fund ETF ((USO - Free Report) ) reversed after reaching the 261.8% fib extension target as volume soared to 1,136% above the 50-day average. Such high volume, violent reversals after climactic moves often coincide with intermediate tops – a bullish sign for equities.
Image Source: TradingView
3. Stocks Tend to Bottom in Mid-March: Over the past two decades, stocks have bottomed in Mid-March more than any other time of year. Is history repeating itself again in 2026?
Image Source: Carson Investment Research
4. Tech Stocks Find Support at the 200-day Moving Average: QQQ retreated to the 200-day moving average for the first time since retaking the long-term trend indicator following last year’s ‘Liberation Day’ bear market.
Image Source: TradingView
Several leading tech stocks such as IREN ((IREN - Free Report) ), NVIDIA ((NVDA - Free Report) ), and Broadcom ((AVGO - Free Report) ) also saw market bulls step in and defend the long-term moving average.
5. Investors are Fearful: According to the CNN Fear & Greed Index, investor fear levels have reached the highest levels of 2026. Typically, extreme bearish sentiment acts as a valuable contrarian indicator for stocks.
Image Source: Zacks Investment Research
Bottom Line
While the Sunday night futures suggested a looming disaster, Monday’s price action proved that the market’s appetite for risk has returned with vengeance. With seasonal tailwinds, cooling geopolitical tensions, and the successful defense of long-term technical levels, the evidence suggests that the path of least resistance has once again tilted to the upside.
Copart has resumed opportunistic share buybacks, deploying $500 million, reflecting disciplined capital allocation and a rational approach to shareholder returns. CPRT's core moat remains intact; the duopoly structure, dominant marketplace, and international expansion underpin the long-term compounding thesis. Recent volume softness is tied to temporary insurance client share shifts, not structural weaknesses or loss of competitive advantage.
2026-03-10 00:231mo ago
2026-03-09 19:331mo ago
Rollins to Present at Upcoming Investor Conferences
, /PRNewswire/ -- Rollins, Inc. (NYSE:ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, today announced that Kenneth Krause, Executive Vice President and Chief Financial Officer, will present at the following events:
Bank of America Information and Business Services Conference at the Bank of America Tower, New York City, New York on Thursday, March 12th from 11:20 a.m. – 11:55 a.m. E.T.
J.P. Morgan Industrials Conference at the Fairmont Washington D.C. Georgetown, on Wednesday, March 18th from 10:45 a.m. – 11:20 a.m. E.T.
These events will be webcast live and can be accessed at https://www.rollins.com/investors/events-presentations. Following the presentations, a replay will be available for 180 days at the link listed above, under the "Events and Presentations" menu. Please note that the schedule above is subject to change.
About Rollins, Inc.
Rollins, Inc. (ROL) is a premier global consumer and commercial services company. Through its family of leading brands, the Company and its franchises provide essential pest control services and protection against termite damage, rodents, and insects to more than 2.8 million customers in North America, South America, Europe, Asia, Africa, and Australia, with approximately 22,000 employees from more than 850 locations. Rollins is parent to Aardwolf Pestkare, Clark Pest Control, Crane Pest Control, Critter Control, Fox Pest Control, HomeTeam Pest Defense, Industrial Fumigant Company, McCall Service, MissQuito, Northwest Exterminating, OPC Pest Services, Orkin, Orkin Australia, Orkin Canada, PermaTreat, Safeguard, Saela Pest Control, Trutech, Waltham Services, Western Pest Services, and more.
You can learn more about Rollins and its subsidiaries by visiting www.rollins.com.
For Further Information Contact:
Lyndsey Burton
(404) 888-2348
SOURCE Rollins, Inc.
2026-03-10 00:231mo ago
2026-03-09 19:331mo ago
Why GitLab Stock Plummeted 24.8% Last Month and Has Kept Falling in March
GitLab (GTLB 1.36%) stock got hit with a precipitous sell-off in February. The company's share price sank 24.8% in the period's trading. The S&P 500 declined 0.9% over the stretch, and the Nasdaq Composite's level fell by 3.4%.
There wasn't any major business-specific news that pushed GitLab's valuation lower last month, but the stock fell in conjunction with a broader-market pivot away from software stocks. Some hotter-than-anticipated inflation data at the end of the month also dragged the company's share price lower.
Image source: Getty Images.
GitLab stock sank amid bearish software pivot and macro concerns Bearish pressure for software stocks mounted in February as investors reacted to the possibility that advances in artificial-intelligence (AI) technologies could render many existing business models obsolete. Amid the more cautious outlook for software stocks, multiple investment firms lowered their one-year price target for GitLab.
GitLab stock also saw a pullback at the end of the month after the Bureau of Labor Statistics (BLS) published its producer-price-index (PPI) report for January. While economists had forecasted inflation of 0.3% for the period, the price index data actually wound up showing a 0.8% increase for the period.
Today's Change
(
-1.36
%) $
-0.34
Current Price
$
24.57
Why GitLab stock has kept falling in March GitLab published its fourth quarter results after the market closed on March 3 and posted sales and earnings that beat Wall Street's targets. The company reported a non-GAAP (adjusted) profit of $0.30 per share on sales of $260.4 million, topping the average analyst estimate's call for a per-share profit of $0.23 on sales of $252.22 million.
Despite the Q4 beats, the company's forward guidance wasn't enough to support gains for the stock. The company's share price is down 6.5% in the month so far.
For the current quarter, GitLab is guiding for sales to be between $253 million and $255 million. The average analyst estimate had called for the business to post sales of $256.69 million. The company expects adjusted earnings per share for the period to be between $0.20 and $0.21 -- roughly in line with the average Wall Street analyst estimate's target for adjusted earnings of $0.20 per share.
Looking ahead to the full-year period, management is targeting sales between $1.099 and $1.118 billion -- falling short of the average analyst estimate's call for revenue of $1.13 billion. Adjusted earnings for the year are projected to be between $0.76 and $0.80, which came in well below the average Wall Street target for earnings of $1.03 per share.
In addition to the weaker-than-expected forward guidance, GitLab stock has lost ground this month as investors reacted to geopolitical and macroeconomic factors. The U.S. and Israel's war with Iran has injected a new source of volatility into the market. BLS data showing that U.S. payroll figures fell by 92,000 in February when economists had only forecasted a reduction of 50,000 jobs has also added to pressures. Along with GitLab's softer-than-anticipated forward guidance, these dynamics have raised concerns about the company's near-term growth outlook.
2026-03-10 00:231mo ago
2026-03-09 19:351mo ago
Santander Investor News: If You Have Suffered Losses in Banco Santander, S.A. (NYSE: SAN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Banco Santander, S.A. (NYSE: SAN) resulting from allegations that Santander may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Santander securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22671 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On February 27, 2026, Reuters published an article entitled “Wall Street hit by UK mortgage lender collapse, raising fears of more credit ‘cockroaches.'” The article stated that “Wall Street lenders on Friday were rocked by the implosion of little-known UK mortgage provider Market Financial Solutions Ltd, fueling concerns about wider losses among banks and reviving warnings of more “cockroaches” in the booming private credit industry.” Further, it stated that Santander faces potential losses from the collapse.
On this news, Santander’s American Depositary Shares (“ADSs”) fell 4.48% on February 27, 2026, and a further 3.2% on February 28, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
2026-03-10 00:231mo ago
2026-03-09 19:351mo ago
BlackRock: Diversification Away From ETFs Comes To Bite
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-03-10 00:231mo ago
2026-03-09 19:361mo ago
GeoPark declines to raise offer for Frontera's Colombia oil and gas assets
CompaniesMarch 9 (Reuters) - Energy firm GeoPark (GPRK.N), opens new tab on Monday decided not to raise its offer for the Colombian oil and gas assets of Frontera Energy (FEC.TO), opens new tab, after Frontera deemed a competing offer from Parex Resources to be "superior."
GeoPark had in January announced a definitive agreement to acquire all of Frontera's oil and gas exploration and production assets in Colombia for $375 million.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
Toronto-listed Frontera said last week that its board and advisors determined the offer from Calgary-based Parex was a "superior proposal."
The Parex offer, first announced in February, is valued at $500 million in cash, including the assumption of debt and a contingent payment of $25 million.
Parex also said the combination would create the largest independent Colombian-focused energy company. The two firms are already partners in Colombia's VIM-1 block.
Frontera, one of Colombia's largest private producers, holds 17 exploration and production blocks, including the Quifa and Cubiro fields. The company reported average production of 38,934 barrels of oil equivalent per day at the end of the third quarter last year.
Reporting by Devika Nair in Bengaluru, Writing by Natalia Siniawski; Editing by Brendan O'Boyle
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Inclusion in a famous family of stock indexes was the fuel propelling Argan's (AGX +12.73%) equity to a double-digit gain on Monday. The industrial construction specialist, already a popular investment thanks to its involvement in artificial intelligence (AI) build-outs of data centers, saw its share price rise by nearly 13% that trading session.
One of 600 After market close on Friday, S&P Dow Jones Indices -- a key business unit of financial information and data company S&P Global -- announced a raft of changes to its indexes.
Image source: Getty Images.
Argan was tapped to join the S&P SmallCap 600 index. It was one of 16 such "graduations" in a class that included stocks such as rideshare company Lyft, dating website operator Match Group, and Sphere Entertainment.
Argan, along with most of the others, will formally become an index component before market open on Monday, March 23.
Today's Change
(
12.73
%) $
52.75
Current Price
$
466.95
Good timing Despite a third-quarter earnings report that missed the consensus analyst revenue estimate -- and therefore led to a brief sell-off -- Argan's stock has done extremely well lately. It's in the right business at the right time with its AI data center activity, and it should also benefit from the Trump administration's desire to build out American infrastructure.
I don't think the S&P SmallCap 600 will make investors any more bullish on the stock than they already are, though it's inarguably a feather in Argan's cap.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lyft and S&P Global. The Motley Fool recommends Match Group. The Motley Fool has a disclosure policy.
2026-03-10 00:231mo ago
2026-03-09 19:381mo ago
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT
Company Participants
Nichol Ochsner - Vice President of Investor Relations & Corporate Communications
Neil McFarlane - President, CEO & Director
Joshua Schafer - Chief Commercial Officer
Justin Renz - Chief Financial Officer
Conference Call Participants
Kristen Kluska - Cantor Fitzgerald & Co., Research Division
Jason Butler - Citizens JMP Securities, LLC, Research Division
Eddie Hickman - Guggenheim Securities, LLC, Research Division
Sumant Kulkarni - Canaccord Genuity Corp., Research Division
Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division
Lachlan Hanbury-Brown - William Blair & Company L.L.C., Research Division
Presentation
Operator
Good afternoon, and thank you for joining Zevra's Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Conference Call. Today's call is being recorded and will be available via the Investor Relations section of the company's website later today. The host for today's call is Nichol Ochsner, Zevra's Vice President of Investor Relations and Corporate Communications.
Nichol Ochsner
Vice President of Investor Relations & Corporate Communications
Thank you, and welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by a review of our fourth quarter and full year 2025 financial results. I encourage you to read the financial results news release, which was distributed this afternoon, and is available in the Investors section of our website.
Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with Zevra's business. Forward-looking statements are not promises or guarantees and are inherently subject to risks, uncertainties and other important factors that may lead to actual results differing materially from the projections made, and should be evaluated together with the Risk Factors section in
2026-03-10 00:231mo ago
2026-03-09 19:381mo ago
Semiconductor ETFs Rally with Bull 3X ETF up 11.6% on Monday
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, surged an astonishing 11.6% on Monday. It was a good day for most stocks with the Dow closing up .5% and the S&P 500 closing up .83%.
Yet, it was a great day across semiconductor stocks. NVIDIA (NVDA) closed up 2.68%, Broadcom (AVG) was up 4.62%. Non-levered ETFs also saw strong gains. The widely followed VanEck Semiconductor ETF (SMH) closed the day up 3.6%. Let’s look at why today went from deep in the red at the market’s open to piling on massive gains across the semiconductor space.
Bouncing Back from Recent Volatility The rally isn’t coming out of nowhere. Semiconductor companies have been delivering the kind of earnings results that remind investors why this sector commands a premium.
NVIDIA set the tone most recently, posting Q4 FY2026 revenue of $68.13 billion, up 73.2% year over year, with Data Center revenue alone hitting $62.31 billion, up 75% year over year. CEO Jensen Huang framed the moment clearly: “The agentic AI inflection point has arrived.” That kind of language, backed by a Q1 FY2027 guidance of approximately $78 billion, is extremely bullish even if shares fell in the following days. NVIDIA is about 18% of VanEck’s holdings.
Broadcom added fuel. The company reported Q1 FY2026 AI chip revenue of $8.4 billion, up 106% year over year, with CEO Hock Tan stating simply: “AI revenue growth is accelerating.” Micron piled on with a significant earnings beat and management noting they expect “business performance to continue strengthening through fiscal 2026.” Best of all, Broadcom pointed to strong visbility into 2027. Days after their report, Marvell (MRVL) announced their earnings and also raised guidance for Fiscal 2027.
The key story here: while NVIDIA’s numbers were great, momentum has been building across the semiconductor space throughout earnings season. With the VanEck Semiconductor ETF having sold off across the past month, the rebound in stocks today led many investors to pile money back into a sector that had taken a recent beating and has had the most promising headlines across earnings season.
ETFs Follow the Sector Higher Non-leveraged funds moved meaningfully today as well. SMH closed at $394.37, up $13.81 on the session, a gain of roughly 3.6%. SOXX closed at $336.37, up $12.86, or about 4.0%. SOXL’s outsized 11.6% move reflects the math of 3x leverage applied to that underlying sector move.
Key Holdings at a Glance Stock Company Current Price Today’s Move YTD Performance NVDA NVIDIA $182.65 +2.72% -2.06% TSM Taiwan Semiconductor $348.70 +2.89% +14.77% AVGO Broadcom $345.75 +4.62% -0.10% MU Micron Technology $389.32 +5.14% +36.41% ASML ASML Holding $1,357.42 +5.00% +27.05% LRCX Lam Research $211.15 +5.93% +23.49% Broader Market Context The VIX closed last week at 29.49, sitting near the top of the elevated uncertainty zone and in roughly the 95th percentile of the past year’s readings. That kind of fear environment typically creates the conditions for sharp sector bounces when sentiment shifts, even briefly. Monday’s semiconductor move fits that pattern.
The 10-year Treasury yield has been drifting higher recently, sitting at 4.15% as of last Friday, but remains below the 12-month average of 4.23%. That relative calm on the rates front removes one headwind that typically weighs on high-multiple tech and semiconductor names.
What to Watch At the end of the day, stocks moved north today because oil prices dropped. Crude futures traded for as high as $120 per barrel last night as Nasdaq Futures dropped 2.7%. As they dropped throughout the day, stocks rallied. WTI Crude now trades for less than $90 per barrel, below where it closed on Friday night. As long as crude futures don’t see a massive rally, stocks will likely avoid any deep losses this week.
2026-03-10 00:231mo ago
2026-03-09 19:461mo ago
Oil Futures Fall Amid Developments That Could Help Supply
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Banco Santander, S.A. (“Banco Santander or the “Company”) (NYSE: SAN) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BANCO SANTANDER, S.A. (SAN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal righ.
2026-03-10 00:231mo ago
2026-03-09 19:541mo ago
GSIT Investor News: If You Have Suffered Losses in GSI Technology Inc. (NASDAQ: GSIT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GSI Technology Inc. (NASDAQ: GSIT) resulting from allegations that GSI Technology may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased GSI Technology securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=52527 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On February 3, 2026, a post was issued on Stockwits in which it stated that “GSI is almost certainly hiding that their chip did not run Gemma-3 at all, only the pre-generation RAG phase. APU lack the MAC units required for matrix multiplication, which is critical for AI workloads.”
On this news, GSI Technology’s stock price fell $1.08 per share, or 14.2%, to close at $6.52 per share on February 4, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
2026-03-10 00:231mo ago
2026-03-09 19:561mo ago
Gold Steady; May Be Supported by Dollar's Weakness
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alight, Inc. (NYSE: ALIT) resulting from allegations that Alight may have issued materially misleading business information to the investing public.
So What: If you purchased Alight securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=54542 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: On February 19, 2026, before the market opened, Alight issued a press release entitled "Alight Reports Fourth Quarter and Full Year 2025 Results". Among other metrics, the release stated disclosed results of "[g]ross profit of $240 million and gross profit margin of 36.8%, compared to $271 million and 39.9% in the prior year period, respectively, and adjusted gross profit of $272 million and adjusted gross profit margin of 41.7%, compared to $300 million and 44.1% in the prior year period, respectively[.]"
On this news, Alight stock fell 38.2% on February 19, 2026.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
2026-03-10 00:231mo ago
2026-03-09 20:001mo ago
Deadline Alert: Apollo Global Management, Inc. (APO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 1, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Apollo Global Management, Inc. ("Apollo" or the "Company") (NYSE: APO) securities between May 10, 2021 and February 21, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR APOLLO GLOBAL MANAGEMENT, INC. INVESTMENTS, CLICK HERE TO INQUIRE ABOUT.
2026-03-10 00:231mo ago
2026-03-09 20:001mo ago
Twin Vee PowerCats Announces Withdrawal of Proposed Public Offering
FORT PIERCE, FL / ACCESS Newswire / March 9, 2026 / Twin Vee PowerCats Co. (NASDAQ:VEEE), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced the withdrawal of the proposed public offering of shares of common stock.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About Twin Vee PowerCats Co.
Twin Vee PowerCats Co. manufactures a range of boats under the Twin Vee and Bahama Boat Works brands, designed for activities including fishing, cruising, and recreational use. Twin Vee PowerCats are recognized for their stable, fuel-efficient, and smooth-riding catamaran hull designs. Twin Vee is one of the most recognizable brand names in the catamaran sport boat category and is known as the "Best Riding Boats on the Water™." Bahama Boat Works is an iconic luxury brand long celebrated for its unmatched craftsmanship, timeless aesthetic, and dedication to producing some of the finest offshore fishing vessels.
The Company is located in Fort Pierce, Florida, and has been building and selling boats for 30 years.
Learn more at twinvee.com and bahamaboatworks.com.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements.
These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company's ability to consummate the offering and the risk factors described in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, the Company's Quarterly Reports on Form 10-Q, the Company's Current Reports on Form 8-K and subsequent filings with the SEC. The information in this release is provided only as of the date of this release, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events, except as required by law.
Securities Fraud Investigation Into Banco Santander, S.A. (SAN) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Banco Santander, S.A. (“Banco Santander” or the “Company”) (NYSE: SAN) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BANCO SANTANDER, S.A. (SAN) CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happ.
2026-03-10 00:231mo ago
2026-03-09 20:001mo ago
Thatcher: High Oil Prices Will Cause Covid-Like Economic Impact
“If you miss a little, you miss a lot” in markets right now, says Ted Thatcher, bringing viewers up to date on the latest oil news. If oil stays around $100/barrel, he thinks we'll see significant economic impact in the next few months, likening it to the Covid-19 pandemic impact.
2026-03-10 00:231mo ago
2026-03-09 20:031mo ago
Circle's 10% Gain Monday Outpaces MSTR and COIN in Big Day for Crypto Stocks
Shares of Circle Internet Group (CRCL) closed up roughly 10% on Monday, with the stock sitting at $111.84 as of the close. That move puts CRCL well ahead of its crypto-adjacent peers today, outpacing both MicroStrategy (MSTR) and Coinbase (COIN) in a session where broader crypto sentiment got a modest lift from Bitcoin.
Strong Earnings and Stablecoin Momentum Drive the Outperformance Circle’s move isn’t coming out of nowhere. The company recently reported a standout quarter, with Q4 2025 revenue of $770.23M, up 76.9% year over year, and an EPS of $0.43 against a $0.25 estimate. That’s the kind of beat that gets attention. USDC, Circle’s flagship stablecoin, saw its circulation hit $75.30B in Q4, up 72% year over year, while on-chain transaction volume exploded to $11.9 trillion, up 247% year over year.
Adjusted EBITDA for Q4 came in at $167M, up 412% year over year. For the full year, adjusted EBITDA doubled to $582M. Circle also received OCC conditional approval for a national trust bank charter, a milestone that signals growing regulatory legitimacy for the stablecoin business model. Add in a 40% multi-year USDC circulation CAGR target, and the bull case starts to write itself.
The analyst community is paying attention. The consensus target price sits at $125.01, with 9 buy ratings, 2 strong buys, and 11 holds among covering analysts. Keep in mind that stablecoins do pretty well in high-interest-rate environments, as yields offered are higher. So, Circle is benefiting from a few key factors.
Outstanding earnings that were recently issued. The size of Circle’s beat has led to price targets rising across Wall Street. The war in Iran leads to a higher likelihood that rates could stay elevated in 2026. If rising oil prices put pressure on inflation, that could lead to the Fed keeping rates elevated across the next year. That’s a risk to most stocks but a relative benefit to Circle. Bitconi had a strong day today, up about 3% from where it traded last night. Bitcoin’s rise is a catalyst across the broader crypto space. MSTR and COIN Lag as Bitcoin Backdrop Remains Soft For context, Bitcoin is trading around $68,400 Monday night, up about 3% on the day but well off the $74,100 intraday high reached on March 4. That softer Bitcoin environment is weighing on the more BTC-correlated names.
MicroStrategy, which holds 713,502 BTC on its balance sheet, closed at $138.95, up 4.06%. Coinbase closed at $199.79, up 1.3%.
Circle’s differentiation here is structural. MSTR’s fortunes are almost entirely tied to Bitcoin’s price. COIN’s transaction revenue is volume-dependent, and its Q4 2025 revenue of $1.80B came in below the $1.83B estimate. Circle earns interest on USDC reserves, which makes its revenue model more predictable and less directly correlated to crypto price swings on any given day. Once again, the company also sees higher benefits from higher rate environments that are becoming more likely as oil volatility rises.
A Recent IPO Still Finding Its Footing It’s worth remembering that CRCL only went public in June 2025. The stock is up 96.21% over the past month and 41.13% year to date. The 52-week high of $298.99 is a reminder of how wide the range has been since listing.
Monday’s outperformance captures exactly what makes Circle’s setup distinct right now. While Bitcoin-sensitive names tread water in a softer crypto environment, Circle’s stablecoin infrastructure business is putting up numbers that stand on their own.
2026-03-10 00:231mo ago
2026-03-09 20:051mo ago
Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SOLENO THERAPEUTICS, INC. (SLNO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What.
2026-03-10 00:231mo ago
2026-03-09 20:081mo ago
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
The Apple Inc. logo is seen hanging at the entrance to the Apple store on 5th Avenue in Manhattan, New York, U.S., October 16, 2019. REUTERS/Mike Segar/File Photo Purchase Licensing Rights, opens new tab
CompaniesBRUSSELS, March 10 (Reuters) - Apple's (AAPL.O), opens new tab proposed changes to its app tracking rules do not resolve antitrust issues in the mobile advertising market, associations representing German publishers and advertisers said on Tuesday as they urged the country's antitrust authority to slap a fine on the U.S. tech giant.
The call by the groups which included media agencies and the German Association of the Branded Goods Industry came three months after the German antitrust authority sought their feedback to Apple's changes to its App Tracking Transparency tool.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Apple did not immediately respond to a request for comment on the statement.
The Cupertino, California-based company has said the tool, which allows users to block advertisers from tracking them across different applications, is designed to allow users to control their privacy.
However, it triggered criticism from Facebook-owner Meta Platforms (META.O), opens new tab, publishers, advertisers and app developers whose business models rely on advertising tracking, prompting the German competition enforcer to charge Apple with abusing its market power in February last year.
To address the German concerns, Apple last December proposed to introduce neutral consent prompts for both its services and third-party apps and to align the wording, content and visual design of these messages.
It also offered to simplify the consent process so developers can obtain user permission for advertising-related data processing in a way that complies with data protection law.
The associations said the proposed changes do not fix the issues outlined by the German watchdog.
"The proposed commitments would not change the negative effects of the App Tracking Transparency Framework," Bernd Nauen, chief executive of the German Advertising Federation, said in a joint letter signed by the trade bodies.
"Apple would remain the data gatekeeper and would continue to decide who gets access to advertising-relevant data and how companies can communicate with their end customers," he said.
The associations urged the watchdog to reject Apple's proposals, order the company to stop the app tracking tool and impose a fine.
Companies found guilty of breaching Germany's antitrust rules risk fines as much as 10% of their annual turnover.
Reporting by Foo Yun Chee; Editing by Lincoln Feast.
Our Standards: The Thomson Reuters Trust Principles., opens new tab
An agenda-setting and market-moving journalist, Foo Yun Chee is a 21-year veteran at Reuters. Her stories on high profile mergers have pushed up the European telecoms index, lifted companies' shares and helped investors decide on their next move. Her knowledge and experience of European antitrust laws and developments helped her break stories on Microsoft, Google, Amazon, Meta and Apple, numerous market-moving mergers and antitrust investigations. She has previously reported on Greek politics and companies, when Greece's entry into the eurozone meant it punched above its weight on the international stage, as well as on Dutch corporate giants and the quirks of Dutch society and culture that never fail to charm readers.
2026-03-10 00:231mo ago
2026-03-09 20:171mo ago
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT
Company Participants
David Fischel - CEO & Chairman
Kimberly Peery - Chief Financial Officer
Conference Call Participants
Daniel Stauder - Citizens JMP Securities, LLC, Research Division
Joshua Jennings - TD Cowen, Research Division
Kyle Bauser - ROTH Capital Partners, LLC, Research Division
Frank Takkinen - Lake Street Capital Markets, LLC, Research Division
Nelson Cox - Lake Street Capital Markets, LLC, Research Division
Kyle Edward Winborne - Piper Sandler & Co., Research Division
Presentation
Operator
Good afternoon. Thank you for joining us for Stereotaxis' Fourth Quarter and Full Year 2025 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to future events, expectations and as such, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company in the future to be materially different from the statements that the company's executives may make today. These risks are described in detail in our public filings with the Securities and Exchange Commission, including our latest periodic report on Form 10-K or 10-Q. We assume no duty to update these statements.
[Operator Instructions]. As a reminder, today's call is being recorded. It is now my pleasure to turn the floor over to your host, David Fischel, Chairman and CEO of Stereotaxis. Thank you.
David Fischel
CEO & Chairman
Thank you, operator. Good afternoon, everyone. This has been a year of tremendous progress. I'm proud of the broad-based technological and commercial progress we've advanced despite operating as a small team in a complex environment with considerable challenges.
During today's call, I'll discuss the key accomplishments of the past year, the primary challenges we're addressing
2026-03-10 00:231mo ago
2026-03-09 20:201mo ago
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masonite International Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOOR
New York, New York--(Newsfile Corp. - March 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June 5, 2023 and February 8, 2024, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.
SO WHAT: If you sold Masonite common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Masonite class action, go to https://rosenlegal.com/submit-form/?case_id=52802 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made material omissions and misrepresentations concerning Owens Corning's offers to purchase all of Masonite's outstanding common stock at significant premiums to Masonite's stock price and Masonite's repurchases of millions of dollars' worth of its shares without disclosing material nonpublic information about Owens Corning's offers, which, if disclosed as required, would have indicated to investors that Masonite's stock was worth significantly more.
To join the Masonite class action, go to https://rosenlegal.com/submit-form/?case_id=52802 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/287786
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-10 00:231mo ago
2026-03-09 20:201mo ago
IDU: Strong Utility Holdings Support Long-Term Upside
iShares U.S. Utilities ETF offers exposure to U.S. utilities with stable demand and historically defensive performance. Top holdings such as NextEra Energy, The Southern Company, and Constellation Energy support the fund's growth and income potential. Rising electricity demand from AI and data centers could drive long-term utility sector growth.
Key Takeaways Adobe headlines the reporting docket this week. The 2026 Q1 earnings season will pick up much more steam in about a month. Sentiment on shares remains rough as AI fears take hold. The 2025 Q4 earnings season is nearly over, with more than 96% of S&P 500 companies already delivering their results. It’s overall been another great cycle, with growth remaining strong while beats percentages aren’t too far off from historical levels.
Adobe (ADBE - Free Report) helps kick off the 2026 Q1 cycle, though the period will pick up much more steam with the release of the big banks’ results, which are due in about a month. But how do expectations stack up for the beaten-down software favorite?
Will AI Disrupt Adobe?
Adobe shares have seen negative sentiment over recent months, with AI disruption fears being reflected in the share performance. While there are still no surefire signs that the company is in imminent danger due to the AI craze, the argument remains valid nonetheless. Most software stocks have faced pressure from the sentiment, with Adobe not alone in this regard.
EPS and sales revisions for the quarter to be reported have also remained stable, with the current $5.88 Zacks Consensus EPS estimate suggesting 15% YoY growth. Revenue revisions paint a similar picture, with the $6.3 billion Zacks Consensus EPS estimate suggesting 10% YoY growth.
Image Source: Zacks Investment Research
Putting It TogetherWhile the stability in estimates is a positive takeaway, Adobe (ADBE - Free Report) still remains vulnerable to a high level of disruption from AI-related technologies, keeping the overall outlook cloudy at this point. It seems like a more risk-averse idea to wait until we hear from the company about its response to the fears, but it’s worth noting that it won’t explicitly state it’s at risk, of course. Guidance and revisions following the earnings report will be a key factor, with the current cloudy outlook not all that reassuring at present.
That being said, the valuation picture here still can’t be overlooked, with the current 11.6X forward 12-month earnings multiple a fraction of the 32.1X five-year median, also reflecting a steep 47% discount relative to the S&P 500. Much of the negativity has likely already been priced in, but that doesn’t necessarily mean that the stock has great upside given the current disruption risks.
2026-03-09 23:231mo ago
2026-03-09 18:531mo ago
Anthropic Challenges SaaS Giants With Claude Marketplace
Anthropic has launched a marketplace for enterprise artificial intelligence (AI) tools, allowing companies with existing spending commitments to apply a portion of those funds toward Claude-powered applications built by third-party developers.
According to Anthropic, the Claude Marketplace, currently in limited preview, launched with six partners: GitLab, Harvey, Lovable, Replit, Rogo and Snowflake.
The move is one of the first attempts by a foundation model provider to evolve into a platform company, extending its commercial footprint beyond model access to applications built on top of it.
The Rise of AI-Native Marketplaces Just as mobile app distribution platforms accelerated the smartphone economy by connecting developers with users through a centralized channel, AI marketplaces could serve as the distribution layer for enterprise software, enabling organizations to find and deploy agents without building solutions from scratch.
Precedent for this logic exists in adjacent markets. For example, Salesforce’s AppExchange, ServiceNow’s store, and AWS Marketplace all highlight that developer ecosystems create competitive moats for platform companies. By following this playbook, Anthropic is betting that the distribution dynamics of software platforms will apply to AI agents, with distribution position becoming as critical as model performance over time.
Other foundation model providers are moving in the same direction. According to Bloomberg, Anthropic modeled aspects of the marketplace on Amazon’s distribution architecture. OpenAI has a GPT Store, Microsoft integrates third-party agents into Copilot, and Google is building out its agent ecosystem through Vertex AI. If the model takes hold, the competition among AI providers may shift from who has the best model to who controls the ecosystem built around it.
Advertisement: Scroll to Continue
How the Billing Architecture Works
We’d love to be your preferred source for news.
Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!
According to Anthropic, enterprises with existing spend commitments can apply a portion of those commitments toward partner tools. Anthropic handles all invoicing, including for third-party products, and partner purchases are credited against the customer’s existing commitment.
That makes Anthropic the central clearinghouse for enterprise AI procurement, consolidating the financial relationship between customers and the tools built on its models. For enterprises, the pitch is fewer vendor contracts and consolidated spend reporting.
Cox Automotive Chief Product Officer Marianne Johnson said in a page about Claude Marketplace that the platform lets her teams move faster by extending their Anthropic investment into partner tools without managing separate procurement processes for each. GitLab wrote in a Friday (March 6) post on X that the arrangement enables organizations to leverage their Anthropic commitments to purchase GitLab and deploy agentic AI across the software development lifecycle. And also in a Friday post on X, Replit said the marketplace consolidates AI spend across Anthropic and Replit and simplifies discovery and procurement.
Ecosystem Control and the Vendor Lock-In Question The strategic intent behind Claude Marketplace goes beyond procurement. By controlling which tools appear in the marketplace, Anthropic acts as a gatekeeper, deciding which solutions enterprises can access through the channel. Partners inside the marketplace reach companies that have already committed spend to Anthropic. Those outside it do not.
That raises concerns about concentration risk. Enterprises that route both model access and application procurement through a single provider may face vendor lock-in. This occurs when existing workflows, custom integrations and investments in specific tools make it complex and costly to switch to another provider, increasing dependency over time.
Whether the marketplace gains traction will depend on how quickly Anthropic can expand beyond its six launch partners and whether enterprises are willing to consolidate their AI strategy around a single provider that supplies both the model and the distribution channel for applications built on it.
According to PYMNTS, Anthropic’s run-rate revenue recently surpassed $19 billion, more than double its figure from three months prior. The marketplace is an attempt to extend that momentum further into enterprise software stacks before competitors build their own distribution layers.
For all PYMNTS AI and digital transformation coverage, subscribe to the daily AI and Digital Transformation Newsletters.
2026-03-09 23:231mo ago
2026-03-09 18:551mo ago
SNOW Investors Have Opportunity to Lead Snowflake Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers Class A common stock of Snowflake Inc. (NYSE: SNOW) between June 27, 2023 and the close of the market on February 28, 2024 (4:00 p.m. ET), inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 27, 2026.
So what: If you purchased Snowflake Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Snowflake class action, go to https://rosenlegal.com/submit-form/?case_id=22950 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, during the Class Period, defendants repeatedly made positive statements about the state of its business, including positive statements about customer usage of, and new developments for, its products. At the same time, defendants failed to disclose that: (1) product efficiency gains, Iceberg Tables and tiered storage pricing were expected to have a material negative impact on consumption and revenues, and (2) as a result, defendants' positive statements about consumption patterns, revenues, and demand for Snowflake products lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Snowflake class action, go to https://rosenlegal.com/submit-form/?case_id=22950 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
2026-03-09 23:231mo ago
2026-03-09 18:571mo ago
RideNow Group, Inc. (RDNW) Q4 2025 Earnings Call Transcript
RideNow Group, Inc. (RDNW) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT
Company Participants
Jerene Makia
Michael Quartieri - CEO, President & Chairman of the Board
Joshua Barsetti - Executive VP & CFO
Conference Call Participants
Eric Wold - Texas Capital Securities, Research Division
Craig Kennison - Robert W. Baird & Co. Incorporated, Research Division
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the RideNow Group, Inc. Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Following the presentation, we will conduct a question-and-answer session. [Operator Instructions]. This call is being recorded on Monday, March 9, 2026. I would now like to turn the conference over to Jerene Makia, VP of Finance. Please go ahead, sir.
Jerene Makia
Thank you, operator. Good afternoon, everyone, and thank you for joining us for RideNow's Fourth Quarter and Full Year 2025 Earnings Conference Call. Joining me on the call today are Michael Quartieri, RideNow's Chairman, Chief Executive Officer and President; and Josh Barsetti, RideNow's Chief Financial Officer.
Our Q4 and full year results are detailed in the press release issued this afternoon and supplemental information will be available in our Form 10-K once filed. Before we begin, I would like to remind you that comments made by management during this conference call may contain forward-looking statements, including, but not limited to, RideNow's market opportunities and future financial results.
All forward-looking statements involve risks and uncertainties, which could affect RideNow's actual results and cause actual results to differ materially from forward-looking statements made by or on behalf of RideNow.
A discussion of material risks and important factors that could affect our results can be found in our filings with the SEC, which are available on our Investor Relations website and at sec.gov.
This conference call also contains time-sensitive information that is
2026-03-09 23:231mo ago
2026-03-09 18:581mo ago
Fluent, Inc. (FLNT) Q4 2025 Earnings Call Transcript
Fluent, Inc. (FLNT) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT
Company Participants
Donald Patrick - Chief Executive Officer
Ryan Perfit - CFO and Principal Financial & Accounting Officer
Conference Call Participants
Maria Ripps - Canaccord Genuity Corp., Research Division
Patrick Sholl - Barrington Research Associates, Inc., Research Division
William Dezellem - Tieton Capital Management, LLC
Presentation
Operator
Good afternoon, and welcome. Thank you for joining us to discuss Fluent's Fourth Quarter and Year-End 2025 earnings results. With me today are Fluent's Chief Executive Officer; Don Patrick, Chief Financial Officer; Ryan Perfit; and Chief Strategy Officer, Ryan Schulke.
Our call today will begin with comments from Don and Ryan Perfit, followed by a question-and-answer session. I would like to remind you that this call is being webcast live and recorded. Additionally, there is a slide presentation that accompanies today's remarks, which can be accessed via the webcast and is also available on Fluent's website. A replay of the event will also be made available following the call on Fluent's website.
To access the webcast and slide presentation, please visit the Investor Relations page at www.fluentco.com. Before we begin, I would like to advise listeners that certain information discussed by management during this conference call will contain forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any forward-looking statements made during this call only speak as of the date hereof. Actual results could differ materially from those stated and implied by such forward-looking statements due to risks and uncertainties associated with the company's business. These statements may be identified by words such as expects, plans, projects, could, will, estimates and other words of similar meaning. The company takes no obligation to update information provided on this call. For a discussion of the risks and uncertainties associated with Fluent's business, we encourage you
2026-03-09 23:231mo ago
2026-03-09 19:001mo ago
50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today
Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada Therapeutics (RLMD) sits at $7.17, also up 61.1% Both moves were absolutely eye-popping, but follow major news that has led investors to re-rate each stock. Clinical data results point to a brighter future ahead for both Xenon and Relmada.
Azetukalner Clears a Major Hurdle for Xenon The big news for XENE hit Monday morning, when Xenon announced that its lead epilepsy drug, azetukalner, met the primary endpoint in the Phase 3 X-TOLE2 study for focal onset seizures. The result: a 53.2% reduction in seizure frequency versus placebo. That is the kind of number that turns a speculative biotech into a near-term commercial story.
The company is now targeting an NDA submission to the FDA in the second half of 2026. Cantor Fitzgerald and Stifel both raised their price targets in response, joining a consensus of 21 analysts with Buy or Strong Buy ratings and an average target price of $56.50 heading into today’s move. The stock has already blown past that consensus, but I would expect more raised targets in the weeks ahead as Wall Street digests these clinical results.
This result matters beyond just one trial. Xenon has five active Phase 3 studies across epilepsy and neuropsychiatry, and long-term open-label extension data showed over 90% reduction in monthly focal onset seizure frequency, with over 38% of patients achieving 12 or more months of seizure freedom. That durability of effect is what separates a drug that gets approved from one that actually gets prescribed.
The company has pro forma cash of $716 million, with runway into the second half of 2027, so there is no near-term financing risk hanging over the NDA process.
Relmada Posts 12-Month NDV-01 Data for Bladder Cancer Relmada Therapeutics’ move is driven by the release today of 12-month Phase 2 interim data for NDV-01, its intravesical treatment for non-muscle-invasive bladder cancer (NMIBC). The 9-month data, reported back in December, already showed a 92% complete response rate with no patients progressing to muscle-invasive disease. Today’s 12-month update is the primary endpoint readout the market has been building toward.
The setup here is genuinely interesting. NMIBC represents approximately 75-80% of all bladder cancer cases, with over 744,000 prevalent U.S. cases. NDV-01 is a sustained-release intravesical formulation of gemcitabine and docetaxel designed for use in community urology settings, not just academic centers. That last point matters because 70-80% of NMIBC patients are currently treated in community settings, which existing formulations largely cannot reach due to pharmacy and administration barriers.
The FDA has already aligned on two separate registrational pathways: a single-arm trial for high-grade BCG-unresponsive NMIBC and a randomized trial for intermediate-risk NMIBC in the adjuvant setting. Both Phase 3 studies are expected to initiate in the first half of 2026.
Leerink Partners projected peak sales of $2.3 billion for NDV-01 when they upgraded the stock to Outperform in January. The current market cap sits at roughly $525 million, so there could be further upside ahead if Relmada keeps delivering stellar results.
What to Watch For XENE, the next milestone is the formal NDA submission later this year. For RLMD, watch for the full 12-month data release and any updated commentary on Phase 3 trial initiation timelines.
2026-03-09 23:231mo ago
2026-03-09 19:011mo ago
Valero Energy (VLO) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest close session, Valero Energy (VLO - Free Report) was down 3.86% at $215.95. This move lagged the S&P 500's daily gain of 0.83%. Meanwhile, the Dow experienced a rise of 0.5%, and the technology-dominated Nasdaq saw an increase of 1.38%.
The stock of oil refiner has risen by 10.83% in the past month, leading the Oils-Energy sector's gain of 7.08% and the S&P 500's loss of 2.65%.
Market participants will be closely following the financial results of Valero Energy in its upcoming release. The company plans to announce its earnings on April 30, 2026. The company's upcoming EPS is projected at $1.86, signifying a 108.99% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $27.85 billion, down 7.97% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.65 per share and revenue of $112.89 billion, which would represent changes of +19.23% and -7.98%, respectively, from the prior year.
Any recent changes to analyst estimates for Valero Energy should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 3.47% higher. Valero Energy currently has a Zacks Rank of #3 (Hold).
From a valuation perspective, Valero Energy is currently exchanging hands at a Forward P/E ratio of 17.75. This valuation marks a premium compared to its industry average Forward P/E of 15.21.
Meanwhile, VLO's PEG ratio is currently 1.18. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. VLO's industry had an average PEG ratio of 1.37 as of yesterday's close.
The Oil and Gas - Refining and Marketing industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 150, which puts it in the bottom 39% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
2026-03-09 23:231mo ago
2026-03-09 19:011mo ago
VALE S.A. (VALE) Surpasses Market Returns: Some Facts Worth Knowing
VALE S.A. (VALE - Free Report) closed the most recent trading day at $15.33, moving +2.4% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. Meanwhile, the Dow experienced a rise of 0.5%, and the technology-dominated Nasdaq saw an increase of 1.38%.
The stock of company has fallen by 8.16% in the past month, lagging the Basic Materials sector's loss of 0.27% and the S&P 500's loss of 2.65%.
The upcoming earnings release of VALE S.A. will be of great interest to investors. The company is predicted to post an EPS of $0.42, indicating a 20% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $9.15 billion, indicating a 12.71% growth compared to the corresponding quarter of the prior year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.1 per share and revenue of $41.18 billion, indicating changes of +15.38% and +7.23%, respectively, compared to the previous year.
Investors should also note any recent changes to analyst estimates for VALE S.A. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.57% lower. As of now, VALE S.A. holds a Zacks Rank of #3 (Hold).
From a valuation perspective, VALE S.A. is currently exchanging hands at a Forward P/E ratio of 7.14. This signifies no noticeable deviation in comparison to the average Forward P/E of 7.14 for its industry.
The Mining - Iron industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 92, this industry ranks in the top 38% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
2026-03-09 23:231mo ago
2026-03-09 19:011mo ago
Vail Resorts (MTN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended January 2026, Vail Resorts (MTN - Free Report) reported revenue of $1.08 billion, down 4.7% over the same period last year. EPS came in at $5.87, compared to $6.56 in the year-ago quarter.
The reported revenue represents a surprise of -2.68% over the Zacks Consensus Estimate of $1.11 billion. With the consensus EPS estimate being $6.06, the EPS surprise was -3.12%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Vail Resorts performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Mountain - Total skier visits: 6.78 thousand versus 7.15 thousand estimated by three analysts on average.Lodging - Managed condominium statistics - RevPAR: $152.98 compared to the $158.82 average estimate based on three analysts.Lodging - Owned hotel statistics - RevPAR: $130.60 compared to the $142.18 average estimate based on three analysts.Mountain - ETP: $92.29 compared to the $90.94 average estimate based on three analysts.Net Revenue- Mountain net revenue: $1.01 billion compared to the $1.03 billion average estimate based on four analysts. The reported number represents a change of -4.8% year over year.Net Revenue- Lodging net revenue: $71.59 million versus $76.41 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -3.2% change.Net Revenue- Mountain net revenue- Dining: $84.63 million compared to the $85.82 million average estimate based on three analysts. The reported number represents a change of -6.9% year over year.Net Revenue- Mountain net revenue- Retail/rental: $126.01 million versus the three-analyst average estimate of $129.13 million. The reported number represents a year-over-year change of -6.8%.Net Revenue- Mountain net revenue- Other: $55.12 million versus the three-analyst average estimate of $56.55 million. The reported number represents a year-over-year change of -6.7%.Net Revenue- Lodging net revenue- Managed condominium rooms: $26.09 million versus $26.92 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -3.6% change.Net Revenue- Mountain net revenue- Ski school: $120.63 million compared to the $122.18 million average estimate based on three analysts. The reported number represents a change of -9.3% year over year.Net Revenue- Mountain net revenue- Lift: $625.93 million compared to the $644.21 million average estimate based on three analysts. The reported number represents a change of -2.9% year over year.View all Key Company Metrics for Vail Resorts here>>>
Shares of Vail Resorts have returned +0.1% over the past month versus the Zacks S&P 500 composite's -2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-03-09 23:231mo ago
2026-03-09 19:011mo ago
Compared to Estimates, Casey's (CASY) Q3 Earnings: A Look at Key Metrics
Casey's General Stores (CASY - Free Report) reported $3.92 billion in revenue for the quarter ended January 2026, representing a year-over-year increase of 0.3%. EPS of $3.49 for the same period compares to $2.33 a year ago.
The reported revenue represents a surprise of -2.65% over the Zacks Consensus Estimate of $4.02 billion. With the consensus EPS estimate being $3.01, the EPS surprise was +16.05%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Casey's performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Number of Stores (EOP): 2,924 versus 2,952 estimated by two analysts on average.Same-store sales - Grocery & General Merchandise - YoY change: 4% compared to the 3.2% average estimate based on two analysts.Number of Fuel gallons sold: 848.43 million versus the two-analyst average estimate of 845.33 million.Same-store sales - Fuel gallons - YoY change: 0.4% versus -0.2% estimated by two analysts on average.Same-store sales - Prepared Food & Dispensed Beverage - YoY change: 4.3% compared to the 4.1% average estimate based on two analysts.Net Sales- Fuel: $2.31 billion compared to the $2.42 billion average estimate based on two analysts. The reported number represents a change of -2.4% year over year.Net Sales- Other: $126.22 million versus the two-analyst average estimate of $131.21 million. The reported number represents a year-over-year change of -7.5%.Net Sales- Prepared Food & Dispensed Beverage: $422.98 million compared to the $428.72 million average estimate based on two analysts. The reported number represents a change of +6.5% year over year.Net Sales- Grocery & General Merchandise: $1.06 billion versus $1.07 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.4% change.Gross Profit- Prepared Food & Dispensed Beverage: $246.48 million compared to the $248.22 million average estimate based on two analysts.Gross Profit- Grocery & General Merchandise: $377.55 million versus the two-analyst average estimate of $368.89 million.View all Key Company Metrics for Casey's here>>>
Shares of Casey's have returned +0.6% over the past month versus the Zacks S&P 500 composite's -2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-03-09 23:231mo ago
2026-03-09 19:021mo ago
GeoPark Announces Decision Not to Raise Offer for Frontera Energy's Colombian E&P Assets
BOGOTA, Colombia--(BUSINESS WIRE)--GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with over 20 years of successful operations across Latin America, today announced that it has declined to raise its offer for Frontera Energy's (“Frontera”) Colombian E&P assets. After careful evaluation, GeoPark's Board of Directors determined that increasing its offer would not be consistent with the Company's disciplined capital allocation framework or long-t.
2026-03-09 23:231mo ago
2026-03-09 19:031mo ago
Water Tower Research Publishes Initiation of Coverage Report on First Phosphate Corp., "Plugging Phosphate into Domestic LFP Battery Ecosystem"
February 26, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on First Phosphate Corp. (OTC: FRSPF) titled, “Plugging Phosphate into Domestic LFP Battery Ecosystem”. The report can be accessed here. First Phosphate Corp. (OTCQX: FRSPF/CSE: PHOS) is a mineral development company that is focused on the exploration and development of high-purity igneous phosphate deposits in Québec, targeting the LFP battery supply chain. The company was incorporated as First Phosphate Corp. in August 2022. The company is headquartered in Saguenay, Québec, positioning it in proximity to its principal mineral assets within the Saguenay–Lac-Saint-Jean region. First Phosphate is advancing a portfolio of 100%-owned claims covering significant anorthosite-hosted phosphate mineralization, which can produce battery-grade PPA without the presence of deleterious heavy metals. The company's strategy is focused on vertically integrating into the North American LFP battery ecosystem by supplying critical phosphate material for cathode active material (CAM) production. As a pre-revenue issuer, its activities are concentrated on resource delineation, metallurgical testing, engineering studies, and strategic partnerships to support future project financing and development. Through its Québec-based asset base and focus on ESG-aligned extraction and processing, First Phosphate aims to become a key domestic supplier of critical phosphate material to the rapidly expanding North American energy storage and EV battery market.
2026-03-09 23:231mo ago
2026-03-09 19:051mo ago
Diversified Energy Announces Pricing of Secondary Offering of Common Stock
March 09, 2026 19:05 ET | Source: Diversified Energy PLC
BIRMINGHAM, Ala., March 09, 2026 (GLOBE NEWSWIRE) -- Diversified Energy Company (NYSE: DEC; LSE: DEC) (“Diversified” or the “Company”), today announced the pricing of the previously announced underwritten public offering (the “Secondary Offering”) by certain funds or entities managed by an affiliate of EIG (collectively, the “Selling Stockholder”) of 7,501,585 shares of Diversified’s common stock, par value $0.01 per share (the “common stock”), which represents all remaining holdings of the Selling Stockholder, at a price to the public of $14.45 per share. Subject to the completion of the Secondary Offering, Diversified has agreed to purchase from the underwriter 3,750,000 shares of common stock at a price per share equal to the price per share paid by the underwriter to the Selling Stockholder in the Secondary Offering (the “repurchase”).
Diversified is not offering any shares of common stock in the Secondary Offering and will not receive any proceeds from the sale of shares of common stock in the Secondary Offering. The Secondary Offering is expected to settle on March 11, 2026, subject to customary closing conditions.
Citigroup is acting as the sole bookrunning manager for the Secondary Offering.
A shelf registration statement relating to the resale of these securities was filed with the U.S. Securities and Exchange Commission (the "SEC") on March 9, 2026 and became effective upon filing. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the Secondary Offering were filed with the SEC and are available free of charge by visiting EDGAR on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus related to the Secondary Offering can be accessed through the SEC’s website free of charge at www.sec.gov or obtained free of charge from the underwriter for the Secondary Offering: Citigroup, c/o Broadridge Financial Solutions, at 1155 Long Island Avenue, Edgewood, NY 11717, or by phone at 800-831-9146.
This announcement does not constitute an offer to sell or the solicitation of an offer to buy our shares of common stock nor shall there be any sale of securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
CONTACTS
Diversified Energy Company+1 973 856 2757Doug [email protected] Vice President, Investor Relations & Corporate Communications About Diversified
Diversified is a leading publicly traded energy company focused on acquiring, operating, and optimizing cash generating energy assets.
Forward-Looking Statements
This announcement contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Forward-looking statements are sometimes identified by the use of forward-looking terminology such as “anticipate”, “believe”, “intend”, “estimate”, “expect”, “may”, “will”, “seek”, “continue”, “aim”, “target”, “projected”, “plan”, “goal”, “achieve”, “guidance”, "outlook" and words of similar meaning, or the negative thereof, other variations thereon or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of management or the Company concerning, among other things, expectations regarding the Secondary Offering, including the repurchase. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond the Company’s ability to control or estimate precisely, such as market conditions, failure of customary closing conditions and the risk factors and other matters set forth in the Company’s filings with the SEC and other important factors that could cause actual results to differ materially from those projected.
Forward-looking statements speak only as of their date and neither the Company nor any of its respective directors, officers, employees, agents, affiliates or advisers expressly disclaim any obligation to supplement, amend, update or revise any of the forward-looking statements made herein, except where it would be required to do so under applicable law. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements in this announcement, may not occur. As a result, you are cautioned not to place undue reliance on such forward-looking statements. Past performance of the Company cannot be relied on as a guide to future performance.
Important Notice to UK and EEA Investors
This announcement contains inside information for the purposes of Regulation (EU) No. 596/2014 on market abuse and Regulation (EU) No. 596/2014 as it forms part of domestic law in the United Kingdom (together, “MAR”).
This announcement is directed at persons who are: (a) if in a member state of the European Economic Area, “qualified investors” within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended (the “Prospectus Regulation”); or (b) if in the United Kingdom, “qualified investors” as defined in paragraph 15 of Schedule 1 of the United Kingdom’s Public Offers and Admissions to Trading Regulations 2024.
This announcement is not being made, and has not been approved, by an authorized person for the purposes of section 21 of the United Kingdom’s Financial Services and Markets Act 2000, as amended. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. This announcement is for distribution only to persons who (i) have professional experience in matters relating to investments and who fall within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Financial Promotion Order”)); (ii) fall within Article 49(2)(a) to (d) of the Financial Promotion Order; (iii) are outside the United Kingdom; or (iv) are other persons to whom it may otherwise lawfully be communicated or distributed under the Financial Promotion Order (for the purposes of this paragraph, all such persons together being referred to as “relevant persons”). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates will be engaged in only with relevant persons. Any person in the United Kingdom that is not a relevant person should not act or rely on this announcement or any documents and/or materials relating to the offer of common stock referred to in this announcement or any of their contents.
No offering document or prospectus will be available in any jurisdiction in connection with the matters contained or referred to in this announcement in the European Economic Area or the United Kingdom and no such offering document or prospectus is required (in accordance with the Prospectus Regulation or the United Kingdom Financial Conduct Authority’s Prospectus Rules: Admission to Trading on a Regulated Market sourcebook) to be published.
Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.